Company news from the 12/12/06 news brief
GlaxoSmithKline (GSK) has entered into an agreement to acquire UK developer of next generation of antibody therapies Domantis for $454 ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.